EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction

Paweł Tyrna iD, Grzegorz Procyk iD, Łukasz Szeleszczuk iD, Izabela Młynarczuk-Biały iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paweł Tyrna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalu…. Hauptthemen laut MEDLINE: Proteasome Inhibitors, Drug Resistance, Neoplasm, Multiple Myeloma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteasome inhibitors (PIs), bortezomib, carfilzomib, and ixazomib, are the first-line treatment for multiple myeloma (MM). They inhibit cytosolic protein degradation in cells, which leads to the accumulation of misfolded and malfunctioned proteins in the cytosol and endoplasmic reticulum, resulting in cell death. Despite being a breakthrough in MM therapy, malignant cells develop resistance to PIs via different mechanisms. Understanding these mechanisms drives research toward new anticancer agents to overcome PI resistance. In this review, we summarize the mechanism of action of PIs and how MM cells adapt to these drugs to develop resistance. Finally, we explore these mechanisms to present strategies to interfere with PI resistance. The strategies include new inhibitors of the ubiquitin–proteasome system, drug efflux inhibitors, autophagy disruption, targeting stress response mechanisms, affecting survival and cell cycle regulators, bone marrow microenvironment modulation, and immunotherapy. We list potential pharmacological targets examined in in vitro, in vivo, and clinical studies. Some of these strategies have already provided clinicians with new anti-MM medications, such as panobinostat and selinexor. We hope that further exploration of the subject will broaden the range of therapeutic options and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome InhibitorsDrug Resistance, NeoplasmMultiple MyelomaHumansAnimalsAntineoplastic AgentsProteasome Endopeptidase ComplexAutophagy

Stichwörter der Autor:innen

molecular medicineproteasome inhibitorstreatment resistance

Substanzen

Proteasome InhibitorsAntineoplastic AgentsProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.
  • 1st Chair and Department of Cardiology, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
  • Department of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-093 Warsaw, Poland.
  • Department of Histology and Embryology, Faculty of Medicine, Warsaw Medical University, Chalubinskiego 5, 02-004 Warsaw, Poland.

ORCID-Profile: Paweł Tyrna, Grzegorz Procyk, Łukasz Szeleszczuk, Izabela Młynarczuk-Biały

Zitieren

APA

Tyrna, P., Procyk, G., Szeleszczuk, Ł., & Młynarczuk-Biały, I. (2024). Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168949

Vancouver

Tyrna P, Procyk G, Szeleszczuk Ł, Młynarczuk-Biały I. Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168949

BibTeX
@article{Tyrna2024,
  author = {Tyrna, Paweł and Procyk, Grzegorz and Szeleszczuk, Łukasz and Młynarczuk-Biały, Izabela},
  title = {Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168949}
}
Kostenlos starten →